Economic Atlas
Companies/Seer, Inc.
Company profile

Seer, Inc.

NASDAQ: SEER · Healthcare · Biotechnology
PublicHQ Redwood City, CA · San MateoCIK 0001726445Reports USD
#577 of 1,422 Healthcare companies by revenue63rd-percentile growth
EA Score
50D
Revenue TTM
$14.7M
Rev growth YoY (TTM)
-2.8%
Net income (FY)
-$73.6M
Employees
124
as of 2026-08-18
Market cap
$111.3M
as of 2026-08-18

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$16.6M$16.6M2025
Net income-$73.6M-$73.6M2025
Operating income-$78.0M-$78.0M2025
Total assets$296.1M$296.1M2025
Liabilities$36.8M$36.8M2025
Equity$259.3M$259.3M2025

Revenue trend

FY2021 – FY2025 · USD
FY21
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2023
By product
Grant100%
By geography

Not disclosed.

The read

What is Seer, Inc.’s revenue?

Seer, Inc. booked $16.6M in FY2025 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -444.0% net margin.

Peers · Healthcare
Pelthos Therapeutics Inc.37DIsodiol International Inc.——Inspire Veterinary Partners, Inc.——Stem Holdings, Inc.——FOXO Technologies Inc.41DProfound Medical Corp.44D
Neighbors
San Mateo →
Meta Platforms, Inc.$201.0B86AGilead Sciences, Inc.$29.4B87AEquinix, Inc.$9.2B74BRobinhood Markets, Inc.$4.5B67BElectronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D
Key facts
CEOOmid C. Farokhzad
SectorHealthcare
IndustryBiotechnology
HeadquartersRedwood City, CA
ExchangeNASDAQ: SEER
Employees124
IPO date2020-12-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.